December 6, 2022
December 6, 2022
Categories

Press Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes

Do you like it?
Read more
October 28, 2022
October 28, 2022
Categories

Press Release: NCI Director Monica Bertagnolli delivers her first public speech at the ECOG-ACRIN Cancer Research Group meeting

Do you like it?
Read more
October 26, 2022
October 26, 2022
Categories

Press Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib

Do you like it?
Read more
October 21, 2022
October 21, 2022
Categories

Press Release: Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting to assess the stage of disease more accurately using standard CT scans

Do you like it?
Read more
October 20, 2022
October 20, 2022
Categories

Press Release: ECOG-ACRIN taps the University of Pennsylvania’s Selina Luger to lead its Leukemia Committee

Do you like it?
Read more
September 27, 2022
September 27, 2022
Categories

Media Advisory: Journal of Clinical Oncology publishes outcomes from the practice-changing DREAMseq trial in patients with advanced melanoma

Do you like it?
Read more
September 8, 2022
September 8, 2022
Categories

Press Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

Do you like it?
Read more
July 14, 2022
July 14, 2022
Categories

Media Advisory: Blood publishes long-term outcomes of patients with CLL in the practice-changing E1912 trial

Do you like it?
Read more
May 27, 2022
May 27, 2022
Categories

Press Release: ECOG-ACRIN research highlights at ASCO 2022

Do you like it?
Read more
Load more
ECOG-ACRIN Cancer Research Group